Schedule 13D ownership disclosure

AKCEA THERAPEUTICS, INC.

Security class unavailable · CUSIP: 00972L107

Event date: 2018-04-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
64,114,545
Percent of class
75.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-027100
Form type
SC 13D/A
Filer
AKCEA THERAPEUTICS, INC.
CIK
CIK 1662524
Filed
Apr 26, 2018
Reporting period
Apr 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub